Clinical trial

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

NCT00003162

Study summary

ClinicalTrials.gov

Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

PROCEDURE · Unmapped registry intervention pain therapy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention radiation therapy Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1998-02-01

PhasePHASE3

Conditions

Breast Cancerverified · MONDO: breast cancer

Metastatic Cancerverified · MONDO: metastatic malignant neoplasm

Painunresolved

Prostate Cancerverified · MONDO: prostate cancer

Interventions

pain therapyPROCEDURE

radiation therapyRADIATION

Sponsors & collaborators

Radiation Therapy Oncology Grouplead sponsor

National Cancer Institute (NCI)collaborator

North Central Cancer Treatment Groupcollaborator

Mapped research locations

PhiladelphiaPennsylvania, United States5 BaltimoreMaryland, United States4 ClevelandOhio, United States4 PittsburghPennsylvania, United States4 MiamiFlorida, United States3 IndianapolisIndiana, United States3 OmahaNebraska, United States3 New OrleansLouisiana, United States3 MilwaukeeWisconsin, United States3 LexingtonKentucky, United States3 New YorkNew York, United States2 Los AngelesCalifornia, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003162 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.